Treatment with Dupixent (dupilumab) — approved in the U.S. for five inflammatory conditions, to date — once again resulted in significantly fewer exacerbations, or periods of sudden symptom worsening, among people with moderate to severe chronic obstructive pulmonary disease (COPD) in the second of two similarly designed Phase 3…
Read more
Note: This column describes the author’s own experiences with phenazopyridine hydrochloride and cranberry juice for urinary tract infections. Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. As November ends here in West Virginia, the chilly weather is confining…
Long-term treatment with Olympus’ Spiration Valve System (SVS) safely led to sustained improvements in lung function — and in life quality — among people with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). That’s according to two-year follow-up data from the EMPOWER trial, which had tested…
No matter how well I plan or how much I want to do something, I have to remember that my chronic obstructive pulmonary disease (COPD) is in control. One such reminder happened two weeks ago, as I was rounding up suitcases, securing a driver, and ensuring my house sitter…
COPD is a chronic inflammatory disease of the lungs, in which the airways become blocked, causing cough with mucus, wheezing, and shortness of breath.
The causes of COPD are not fully understood. However, long-term exposure to lung irritants is known to damage the lungs and the airways.
Some people may also experience exacerbations, or episodes of sudden disease worsening, that may persist for several days.
Get regular updates to your inbox.
